BioGlue and E-Vita Open NEO graft oozing: Long-term solution or band aid?

​Author(s): Jubouri M; Hull York Medical School, University of York
Abdelhaliem A; Department of Vascular and Endovascular Surgery, Royal Blackburn Teaching Hospital
Source: Journal of Cardiac Surgery, 2021 Dec
Abstract: The introduction of the single-step total arch replacement (TAR) with frozen elephant trunk (FET) has revolutionised the field of aortic surgery. TAR is indicated when the aortic arch is involved in aortic pathologies such as Type A aortic dissection and thoracic aortic aneurysms. Several FET devices are available commercially for global use, and example is the E-Vita Open NEO hybrid prosthesis (HP) developed by CryoLife-JOTEC. Unlike other FET devices available, this HP in particular features a design that puts it at a disadvantage as it does not incorporate gelatine or collagen in its structure, which makes it permeable to blood. Several studies have reported incidence of post-anastomotic blood oozing through the E-Vita Open NEO right after weaning from cardiopulmonary bypass. This commentary aims to discuss the recent study by Tan et al. which investigated E-Vita NEO device oozing as well as the implications of using BioGlue to overcome this serious complications.

• Available here https://onlinelibrary.wiley.com/doi/epdf/10.1111/jocs.16181